Log In
BCIQ
Print this Print this
 

Type I interferon (IFN) receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Type I interferon (IFN) receptor

BCIQ
Print ChartPrint this
Marketed, 7 Marketed, 2 Marketed, 5 Approved, 2 Approved, 1 Phase II/III, 1 Phase II, 1 Phase II, 1 Phase II, 5 Phase II, 1 Phase I/II, 1 Pilot, 1 Preclinical, 3
Phase of DevelopmentPreclinicalPilotPhase I/IIPhase IIPhase II/IIIApprovedMarketed
Autoimmune

-

-

-

1

-

-

5

Cancer

-

-

-

-

-

1

2

Infectious

3

1

1

5

1

2

7

Inflammation

-

-

-

1

-

-

-

Pulmonary

-

-

-

1

-

-

-




 Products Targeting Type I interferon (IFN) receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

12

$944.2M

$417.7M

$285.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today